These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23983120)

  • 1. Transient exposure of pulmonary surfactant to hyaluronan promotes structural and compositional transformations into a highly active state.
    Lopez-Rodriguez E; Cruz A; Richter RP; Taeusch HW; Pérez-Gil J
    J Biol Chem; 2013 Oct; 288(41):29872-81. PubMed ID: 23983120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilayers at the surface of solutions of exogenous lung surfactant: direct observation by neutron reflection.
    Follows D; Tiberg F; Thomas RK; Larsson M
    Biochim Biophys Acta; 2007 Feb; 1768(2):228-35. PubMed ID: 17156743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-lipid interactions and surface activity in the pulmonary surfactant system.
    Serrano AG; Pérez-Gil J
    Chem Phys Lipids; 2006 Jun; 141(1-2):105-18. PubMed ID: 16600200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Surfactant Lipid Reorganization Induced by the Adsorption of the Oligomeric Surfactant Protein B Complex.
    Liekkinen J; Enkavi G; Javanainen M; Olmeda B; Pérez-Gil J; Vattulainen I
    J Mol Biol; 2020 May; 432(10):3251-3268. PubMed ID: 32135191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.
    López-Rodríguez E; Ospina OL; Echaide M; Taeusch HW; Pérez-Gil J
    Biophys J; 2012 Oct; 103(7):1451-9. PubMed ID: 23062337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.
    Zasadzinski JA; Alig TF; Alonso C; Bernardino de la Serna J; Perez-Gil J; Taeusch HW
    Biophys J; 2005 Sep; 89(3):1621-9. PubMed ID: 16006630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition.
    Echaide M; Autilio C; López-Rodríguez E; Cruz A; Pérez-Gil J
    Sci Rep; 2020 Jan; 10(1):1385. PubMed ID: 31992800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan decreases surfactant inactivation in vitro.
    Lu KW; Goerke J; Clements JA; Taeusch HW
    Pediatr Res; 2005 Feb; 57(2):237-41. PubMed ID: 15585679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.
    Taeusch HW; Dybbro E; Lu KW
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):243-9. PubMed ID: 18065212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation to low body temperature influences pulmonary surfactant composition thereby increasing fluidity while maintaining appropriately ordered membrane structure and surface activity.
    Suri LN; McCaig L; Picardi MV; Ospina OL; Veldhuizen RA; Staples JF; Possmayer F; Yao LJ; Perez-Gil J; Orgeig S
    Biochim Biophys Acta; 2012 Jul; 1818(7):1581-9. PubMed ID: 22387458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segregated ordered lipid phases and protein-promoted membrane cohesivity are required for pulmonary surfactant films to stabilize and protect the respiratory surface.
    Bernardino de la Serna J; Vargas R; Picardi V; Cruz A; Arranz R; Valpuesta JM; Mateu L; Pérez-Gil J
    Faraday Discuss; 2013; 161():535-48; discussion 563-89. PubMed ID: 23805757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophobic surfactant proteins and their analogues.
    Walther FJ; Waring AJ; Sherman MA; Zasadzinski JA; Gordon LM
    Neonatology; 2007; 91(4):303-10. PubMed ID: 17575474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption of pulmonary surfactant protein SP-A to monolayers of phospholipids containing hydrophobic surfactant protein SP-B or SP-C: potential differential role for tertiary interaction of lipids, hydrophobic proteins, and SP-A.
    Taneva SG; Keough KM
    Biochemistry; 2000 May; 39(20):6083-93. PubMed ID: 10821681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics.
    Gómez-Gil L; Schürch D; Goormaghtigh E; Pérez-Gil J
    Biophys J; 2009 Nov; 97(10):2736-45. PubMed ID: 19917227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant.
    Fan Q; Wang YE; Zhao X; Loo JS; Zuo YY
    ACS Nano; 2011 Aug; 5(8):6410-6. PubMed ID: 21761867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-cooperative effects of lung surfactant proteins on early adsorption to an air/water interface.
    Schram V; Anyan WR; Hall SB
    Biochim Biophys Acta; 2003 Oct; 1616(2):165-73. PubMed ID: 14561474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.
    Zasadzinski JA; Stenger PC; Shieh I; Dhar P
    Biochim Biophys Acta; 2010 Apr; 1798(4):801-28. PubMed ID: 20026298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interfacial properties of pulmonary surfactant layers.
    Wüstneck R; Perez-Gil J; Wüstneck N; Cruz A; Fainerman VB; Pison U
    Adv Colloid Interface Sci; 2005 Dec; 117(1-3):33-58. PubMed ID: 16120435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid components of the synthetic pulmonary surfactant CHF5633 probed by fluorescence spectroscopy.
    Faggiano S; Ronda L; Raboni S; Sartor F; Cavatorta V; Sgarbi E; Caivano G; Pertile M; Mozzarelli A
    Int J Pharm; 2018 Dec; 553(1-2):290-297. PubMed ID: 30366070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.